Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
13,987
Total Claims
$2.0M
Drug Cost
802
Beneficiaries
$2,481
Cost/Patient
Risk Score Breakdown 20/100
Score components are additive. Read full methodology
Peer Comparison vs. 109,535 Physician Assistant providers
-70%
Opioid rate vs peers
2.7% vs 9.2% avg
+245%
Cost per patient vs peers
$2,481 vs $719 avg
+143%
Brand preference vs peers
16.2% vs 6.7% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
2.7%
Opioid Rate
383
Opioid Claims
$14K
Opioid Cost
12.3%
Long-Acting Rate
Brand vs Generic
Brand: 2,235 claims · $1.7M
Generic: 11,599 claims · $263K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Empagliflozin/Metformin Hcl | 199 | $190K |
| Dulaglutide | 123 | $177K |
| Empagliflozin | 125 | $124K |
| Fluticasone/Umeclidin/Vilanter | 117 | $107K |
| Apixaban | 83 | $88K |
| Semaglutide | 62 | $83K |
| Mirabegron | 136 | $71K |
| Dapagliflozin Propanediol | 53 | $63K |
| Insulin Glargine,hum.Rec.Anlog | 46 | $50K |
| Insulin Glargine,hum.Rec.Anlog | 51 | $44K |
| Semaglutide | 33 | $44K |
| Insulin Degludec | 20 | $43K |
| Dapaglifloz Propaned/Metformin | 38 | $41K |
| Sitagliptin Phosphate | 44 | $35K |
| Liraglutide | 24 | $33K |
Prescribing Profile
Patient Profile
71
Avg Age
54%
Female
1.13
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data